Active Ingredient: TIZANIDINE HYDROCHLORIDE
Proprietary Name: ZANAFLEX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020397
Product Number: 002
Approval Date: Feb 4, 2000
Applicant Holder Full Name: LEGACY PHARMA USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information